Skip to main content
Erschienen in: Neurological Sciences 8/2013

01.08.2013 | Original Article

Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement

verfasst von: Duygu Gezen-Ak, Erdinç Dursun, Selma Yilmazer

Erschienen in: Neurological Sciences | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Vitamin D receptor (VDR) and the enzymes involved in bioactivation of vitamin D, shown to be expressed in the central nervous system, particularly in areas affected by neurodegenerative disorders, especially in hippocampus. We showed that amyloid beta (Aβ) pathology includes VDR protein depletion and vitamin D-VDR pathway disruption either induced by Aβ or by VDR siRNA have very similar effects on cortical neurons. The goal of this study is to show the presence of 25 hydroxy vitamin D3-24 hydroxylase (24OHase) which is essential for vitamin D catabolism in hippocampal and cortical neurons. Additional goal is to compare the expression pattern of VDR and 24OHase both in hippocampal and in cortical neurons and to investigate the effects of VDR suppression in hippocampal neurons in order to see whether similar mechanisms work in hippocampus and cerebral cortex. Primary neuronal cultures were prepared from Sprague–dawley rat embryos. qRT-PCR was performed to determine VDR, 24OHase, and LVSCC-A1C mRNA expression levels. Cytotoxicity levels were determined by ELISA. Our findings illustrate that 24OHase mRNA was present both in hippocampal and in cortical neurons. VDR and 24OHase mRNA were higher in hippocampal neurons than the cortical ones. LVSCC-A1C mRNA levels increased in hippocampal neurons when VDR is down-regulated. Our results indicate that hippocampal neurons response to VDR suppression similar as cortical neurons, regarding calcium channel regulation. Higher gene expression of 24OHase and VDR might indicate “higher requirement of vitamin D” in hippocampus and potential consequences of vitamin D deficiency in cognitive decline, neurodegeneration, and Alzheimer’s disease.
Literatur
1.
Zurück zum Zitat Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8:13–19CrossRef Bouillon R, Carmeliet G, Daci E, Segaert S, Verstuyf A (1998) Vitamin D metabolism and action. Osteoporos Int 8:13–19CrossRef
2.
Zurück zum Zitat Brown J, Bianco JI, McGrath JJ, Eyles DW (2003) 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343:139–143PubMedCrossRef Brown J, Bianco JI, McGrath JJ, Eyles DW (2003) 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 343:139–143PubMedCrossRef
3.
Zurück zum Zitat Cekic M, Sayeed I, Stein DG (2009) Combination treatment with progesterone and vitamin d hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrin 30:158–172CrossRef Cekic M, Sayeed I, Stein DG (2009) Combination treatment with progesterone and vitamin d hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrin 30:158–172CrossRef
4.
Zurück zum Zitat Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100–105PubMedCrossRef Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13(3):100–105PubMedCrossRef
5.
Zurück zum Zitat Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y (2001) Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 904:67–75PubMedCrossRef Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, Wang Y (2001) Vitamin D3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res 904:67–75PubMedCrossRef
6.
Zurück zum Zitat F′eron F, Burne THJ, Brown J, Smith E, McGrath JJ, Mackay-Sima A, Eyles DW (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65(2):141–148CrossRef F′eron F, Burne THJ, Brown J, Smith E, McGrath JJ, Mackay-Sima A, Eyles DW (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 65(2):141–148CrossRef
7.
Zurück zum Zitat Khazai N, Judd SE, Tangpricha V (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10:110–117PubMedCrossRef Khazai N, Judd SE, Tangpricha V (2008) Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep 10:110–117PubMedCrossRef
8.
Zurück zum Zitat Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, Roque M (2001) Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc) 117:611–614CrossRef Larrosa M, Gratacos J, Vaqueiro M, Prat M, Campos F, Roque M (2001) Prevalence of hypovitaminosis D in elderly institutionalized residents: influence of a substitutive treatment. Med Clin (Barc) 117:611–614CrossRef
9.
Zurück zum Zitat Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74(1):27–32PubMedCrossRef Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74(1):27–32PubMedCrossRef
10.
Zurück zum Zitat Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O (2011) Alzheimer’s disease–input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial. Trials 12:230PubMedCrossRef Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O (2011) Alzheimer’s disease–input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial. Trials 12:230PubMedCrossRef
11.
Zurück zum Zitat Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O (2012) Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 32:273–278CrossRef Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O (2012) Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 32:273–278CrossRef
12.
Zurück zum Zitat Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O (2012) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 19(7):1023–1029 Annweiler C, Fantino B, Schott AM, Krolak-Salmon P, Allali G, Beauchet O (2012) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 19(7):1023–1029
13.
Zurück zum Zitat Buell JS, Dawson-Hughes B (2008) Vitamin D and neurocognitive dysfunction: preventing “D” ecline? Mol Aspects Med 29(6):415–422PubMedCrossRef Buell JS, Dawson-Hughes B (2008) Vitamin D and neurocognitive dysfunction: preventing “D” ecline? Mol Aspects Med 29(6):415–422PubMedCrossRef
14.
Zurück zum Zitat Cherniack EP, Florez H, Roos BA, Troen BR, Levis S (2008) Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 12(6):366–373PubMedCrossRef Cherniack EP, Florez H, Roos BA, Troen BR, Levis S (2008) Hypovitaminosis D in the elderly: from bone to brain. J Nutr Health Aging 12(6):366–373PubMedCrossRef
15.
Zurück zum Zitat Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ (2011) Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 25(8):629–639PubMedCrossRef Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ (2011) Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 25(8):629–639PubMedCrossRef
16.
Zurück zum Zitat Evatt ML, DeLong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin D insufficiency in patients with parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348–1352PubMedCrossRef Evatt ML, DeLong MR, Khazai N, Rosen A, Triche S, Tangpricha V (2008) Prevalence of vitamin D insufficiency in patients with parkinson disease and Alzheimer disease. Arch Neurol 65(10):1348–1352PubMedCrossRef
17.
Zurück zum Zitat Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22(3):188–195PubMedCrossRef Llewellyn DJ, Langa KM, Lang IA (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 22(3):188–195PubMedCrossRef
18.
Zurück zum Zitat Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170(13):1135–1141PubMedCrossRef Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 170(13):1135–1141PubMedCrossRef
19.
Zurück zum Zitat Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM (2008) Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 25:539–543PubMedCrossRef Oudshoorn C, Mattace-Raso FUS, van der Velde N, Colin EM, van der Cammen TJM (2008) Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord 25:539–543PubMedCrossRef
20.
Zurück zum Zitat Summerday NM, Brown SJ, Allington DR, Rivey MP (2012) Vitamin D and multiple sclerosis : review of a possible association. J Pharm Pract 25:75–84PubMedCrossRef Summerday NM, Brown SJ, Allington DR, Rivey MP (2012) Vitamin D and multiple sclerosis : review of a possible association. J Pharm Pract 25:75–84PubMedCrossRef
21.
Zurück zum Zitat Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriat Psychiat 14:1032–1040CrossRef Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriat Psychiat 14:1032–1040CrossRef
22.
Zurück zum Zitat Fleet JC (2004) Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: what are they and what do they mean? J Nutr 134:3215–3218PubMed Fleet JC (2004) Rapid, membrane-initiated actions of 1,25 dihydroxyvitamin D: what are they and what do they mean? J Nutr 134:3215–3218PubMed
23.
Zurück zum Zitat Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ (2010) Vitamin D: metabolism. Endocrinol Metab Clin N Am 39(2):243–253CrossRef Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ (2010) Vitamin D: metabolism. Endocrinol Metab Clin N Am 39(2):243–253CrossRef
24.
Zurück zum Zitat Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21–30PubMedCrossRef Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29:21–30PubMedCrossRef
25.
Zurück zum Zitat Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RGJ, Van Heemst D (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30:466–473PubMedCrossRef Kuningas M, Mooijaart SP, Jolles J, Slagboom PE, Westendorp RGJ, Van Heemst D (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol Aging 30:466–473PubMedCrossRef
26.
Zurück zum Zitat Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 95:163–178PubMedCrossRef Beydoun MA, Ding EL, Beydoun HA, Tanaka T, Ferrucci L, Zonderman AB (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 95:163–178PubMedCrossRef
27.
Zurück zum Zitat Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith DA (2011) The vitamin D receptor gene is associated with Alzheimer’s disease. Neurosci Let 504:79–82CrossRef Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith DA (2011) The vitamin D receptor gene is associated with Alzheimer’s disease. Neurosci Let 504:79–82CrossRef
28.
Zurück zum Zitat Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S (2007) Association between vitamin D receptor gene polymorphism and Alzheimer’s disease. Tohoku J Exp Med 212:275–282PubMedCrossRef Gezen-Ak D, Dursun E, Ertan T, Hanagasi H, Gurvit H, Emre M, Eker E, Ozturk M, Engin F, Yilmazer S (2007) Association between vitamin D receptor gene polymorphism and Alzheimer’s disease. Tohoku J Exp Med 212:275–282PubMedCrossRef
29.
Zurück zum Zitat Gezen-Ak D, Dursun E, Bilgiç B, Hanağasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal Ö, Yilmazer S (2012) Vitamin D receptor gene haplotype is associated with late-onset Alzheimer’s disease. Tohoku J Exp Med 228:189–196PubMedCrossRef Gezen-Ak D, Dursun E, Bilgiç B, Hanağasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal Ö, Yilmazer S (2012) Vitamin D receptor gene haplotype is associated with late-onset Alzheimer’s disease. Tohoku J Exp Med 228:189–196PubMedCrossRef
30.
Zurück zum Zitat Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 75(2):201–210PubMedCrossRef Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann Hum Genet 75(2):201–210PubMedCrossRef
31.
Zurück zum Zitat Dhawan P, Christakos S (2010) Novel regulation of 25-hydroxy vitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBPb, and the vitamin D receptor in 24(OH)ase transcription. J Cell Biochem 110:1314–1323PubMedCrossRef Dhawan P, Christakos S (2010) Novel regulation of 25-hydroxy vitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBPb, and the vitamin D receptor in 24(OH)ase transcription. J Cell Biochem 110:1314–1323PubMedCrossRef
33.
Zurück zum Zitat Dursun E, Gezen-Ak D, Yilmazer S (2011) A novel perspective for Alzheimer’s disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimer’s Dis 23:207–219 Dursun E, Gezen-Ak D, Yilmazer S (2011) A novel perspective for Alzheimer’s disease: vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons. J Alzheimer’s Dis 23:207–219
34.
Zurück zum Zitat Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6:85–94PubMedCrossRef Mu Y, Gage FH (2011) Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Mol Neurodegener 6:85–94PubMedCrossRef
35.
Zurück zum Zitat Price P, Brewer GJ (1998) Serum-free media for neural cell cultures. In: Fedoroff S, Richardson A (eds) Protocols for neural cell culture, 3rd edn. Humana Press, New Jersey, pp 255–264 Price P, Brewer GJ (1998) Serum-free media for neural cell cultures. In: Fedoroff S, Richardson A (eds) Protocols for neural cell culture, 3rd edn. Humana Press, New Jersey, pp 255–264
36.
Zurück zum Zitat Keisala TMA, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P (2009) Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115:91–97PubMedCrossRef Keisala TMA, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P (2009) Premature aging in vitamin D receptor mutant mice. J Steroid Biochem Mol Biol 115:91–97PubMedCrossRef
37.
Zurück zum Zitat Yamaguchi M (2002) Impact of aging on calcium channels and pumps. Adv Cell Aging Gero 10:47–65CrossRef Yamaguchi M (2002) Impact of aging on calcium channels and pumps. Adv Cell Aging Gero 10:47–65CrossRef
38.
Zurück zum Zitat Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34:385–397PubMedCrossRef Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer’s disease. Cell Calcium 34:385–397PubMedCrossRef
39.
Zurück zum Zitat Mizwicki MT, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, Cashman JR, Griffin PR, Fiala M (2012) Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer’s disease macrophages. J Alzheimer’s Dis 29(1):51–62 Mizwicki MT, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, Cashman JR, Griffin PR, Fiala M (2012) Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer’s disease macrophages. J Alzheimer’s Dis 29(1):51–62
40.
Zurück zum Zitat Fiala M, Mizwicki MT (2011) Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients. Funct Foods Health Dis 12:545–554 Fiala M, Mizwicki MT (2011) Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients. Funct Foods Health Dis 12:545–554
Metadaten
Titel
Vitamin D inquiry in hippocampal neurons: consequences of vitamin D-VDR pathway disruption on calcium channel and the vitamin D requirement
verfasst von
Duygu Gezen-Ak
Erdinç Dursun
Selma Yilmazer
Publikationsdatum
01.08.2013
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 8/2013
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1268-6

Weitere Artikel der Ausgabe 8/2013

Neurological Sciences 8/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.